文献速递心脑血管急症

风险因素达最佳、临界或升高水平时的房颤终生风险:基于弗雷明汉心脏研究纵向数据的队列研究

Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study.
PubMed 文献 · BMJ · 2018-04-26
一句话结论在55、65或75岁时,风险因素达最佳水平者终生房颤风险约五分之一,至少一项风险因素升高者超过三分之一。

该社区队列研究基于弗雷明汉心脏研究纵向数据,评估55、65、75岁无房颤个体的吸烟、饮酒、体重指数、血压、糖尿病及心衰或心梗病史,分为最佳、临界或升高风险因素负荷。在55岁指数年龄的5338名参与者中,最佳、临界、升高风险负荷者分别占4.6%、26.5%、68.9%。55岁时终生房颤风险总体为37.0%,最佳风险负荷者为23.4%,临界为33.4%,升高为38.4%。65岁和75岁指数年龄的风险梯度相似。结论指出,无论指数年龄为55、65或75岁,最佳风险因素负荷与约五分之一的终生房颤风险相关,而至少一项风险因素升高者风险升至超过三分之一。

要点

  • 55岁指数年龄时,最佳风险负荷者终生房颤风险为23.4%(95%CI 12.8%至34.5%),临界为33.4%(27.9%至38.9%),升高为38.4%(35.5%至41.4%)。
  • 55岁指数年龄总体终生房颤风险为37.0%(95%CI 34.3%至39.6%)。
  • 至少一项风险因素升高者终生房颤风险至少为37.8%。
  • 65岁和75岁指数年龄时,终生风险随风险因素负荷的梯度相似。
  • 55岁指数年龄样本中,仅4.6%为最佳风险负荷,68.9%为升高风险负荷。

适用人群与场景

  • 弗雷明汉心脏研究纵向数据中,指数年龄55、65、75岁时无房颤的个体。
  • 评估的风险因素包括吸烟、饮酒、体重指数、血压、糖尿病及心衰或心梗病史。

诊断标准与关键阈值

  • 最佳风险负荷:所有风险因素均为最佳。
  • 临界风险负荷:存在临界风险因素且无任何升高风险因素。
  • 升高风险负荷:至少存在一项升高风险因素。

研究设计与关键结果

  • 社区队列研究,基于弗雷明汉心脏研究纵向数据;55岁指数年龄样本5338人(47.4%为男性),其中最佳风险负荷247人(4.6%)、临界1415人(26.5%)、升高3676人(68.9%)。
  • 55岁指数年龄终生房颤风险总体为37.0%(95%CI 34.3%至39.6%);最佳风险负荷为23.4%(95%CI 12.8%至34.5%),临界为33.4%(95%CI 27.9%至38.9%),升高为38.4%(95%CI 35.5%至41.4%)。
  • 至少一项风险因素升高者终生房颤风险至少为37.8%。
  • 随指数年龄升高,升高风险因素的患病率逐渐增加;65岁和75岁指数年龄时终生风险梯度相似。

证据类型、等级与局限

  • 证据类型:社区 based 队列研究。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者结论认为,无论指数年龄为55、65或75岁,最佳风险因素负荷与约五分之一的终生房颤风险相关,而至少一项升高风险因素者风险升至超过三分之一。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To examine the association between risk factor burdens-categorized as optimal, borderline, or elevated-and the lifetime risk of atrial fibrillation.

DESIGN: Community based cohort study.

SETTING: Longitudinal data from the Framingham Heart Study.

PARTICIPANTS: Individuals free of atrial fibrillation at index ages 55, 65, and 75 years were assessed. Smoking, alcohol consumption, body mass index, blood pressure, diabetes, and history of heart failure or myocardial infarction were assessed as being optimal (that is, all risk factors were optimal), borderline (presence of borderline risk factors and absence of any elevated risk factor), or elevated (presence of at least one elevated risk factor) at index age.

MAIN OUTCOME MEASURE: Lifetime risk of atrial fibrillation at index age up to 95 years, accounting for the competing risk of death.

RESULTS: At index age 55 years, the study sample comprised 5338 participants (2531 (47.4%) men). In this group, 247 (4.6%) had an optimal risk profile, 1415 (26.5%) had a borderline risk profile, and 3676 (68.9%) an elevated risk profile. The prevalence of elevated risk factors increased gradually when the index ages rose. For index age of 55 years, the lifetime risk of atrial fibrillation was 37.0% (95% confidence interval 34.3% to 39.6%). The lifetime risk of atrial fibrillation was 23.4% (12.8% to 34.5%) with an optimal risk profile, 33.4% (27.9% to 38.9%) with a borderline risk profile, and 38.4% (35.5% to 41.4%) with an elevated risk profile. Overall, participants with at least one elevated risk factor were associated with at least 37.8% lifetime risk of atrial fibrillation. The gradient in lifetime risk across risk factor burden was similar at index ages 65 and 75 years.

CONCLUSIONS: Regardless of index ages at 55, 65, or 75 years, an optimal risk factor profile was associated with a lifetime risk of atrial fibrillation of about one in five; this risk rose to more than one in three a third in individuals with at least one elevated risk factor.

来源:BMJ,查看原文。版权归原作者所有。

参考来源

  1. Staerk L, Wang B, Preis SR, et al. Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study. BMJ. 2018. PMID: 29699974. doi:10.1136/bmj.k1453

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。